跳至主要内容
临床试验/NCT04188327
NCT04188327已完成不适用

Utility of Early Serial Stellate Ganglion Block in Acute Herpes Zoster of Face and Neck

Tanta University5 个研究点 分布在 1 个国家目标入组 208 人开始时间: 2020年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
208
试验地点
5
主要终点
Incidence of Post-herpetic neuralgia

研究概览

简要总结

Patient who will be presented to Tanta University Hospitals complaining of acute herpes zoster with onset of vesicular eruption less than 7 days will be included in this clinical study.

Patients will be excluded if they refused participation, had allergy to local anesthetics, coagulopathy, local infection, glaucoma, or neurological deficit.

All the patients will receive acyclovir (antiviral therapy) and pregablin (analgesic) and the patients will be classified into two groups:- Group I (control group): Patients will receive sham block weekly for three times Group III (SGB group): Patients will receive stellate ganglion block weekly for three times

The time of first block after the onset of vesicular eruption, the incidence of PHN, NPRS at visit, duration of acute HZ , duration of PHN (if occurred), and the incidence of complication will be measured.

详细描述

This prospective randomized study will be carried out on adult patients complaining of acute herpes zoster presented at Tanta University Hospitals after approval from ethics committee for twelve months.

An informed consent will be taken from each patient. All data of patients will be confidential with secret codes and private file for each patient. All given data will be used for the current medical research only.

Any unexpected risk encountered during the course of the research will be cleared to the participant as well as to the Ethical Committee on time. Every patient will receive an explanation to the purpose of the study and will have a secret code number to ensure privacy of the participants and confidentiality of their data.

The study will be terminated in case of incidence of severe hypotension no responding to ephedrine (Mean arterial blood pressure less than 60 mmHg) or severe bradycardia not responding to atropine (Heart rate less than 40 b/min). The participants and the ethical committee will be announced.

There will be adequate supervision to maintain the privacy of patients and confidentiality of data. There will be no conflict of interest, nor conflict with religion, law, or society standards. The research will be beneficial to the society and has no risk of environmental pollution.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

  • The patients will be blind through the use of closed sealed envelops.
  • The investigator will be blind through the use of sham block in the control group.
  • The measurement will be collected by anesthesiologist not participating in the study and blinded to its group

入排标准

年龄范围
60 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who is presented to the pain clinic, diagnosed with acute herpes zoster of the face and/ or neck with onset of vesicular eruption less than seven days

排除标准

  • Patient refusal or un-cooperation
  • Known history of allergy to local anesthetics
  • Local infection at the site of the block
  • Platelet count less than 75,000/ cc
  • Neurological deficit in the upper limb
  • Bradycardia

结局指标

主要结局

Incidence of Post-herpetic neuralgia

时间窗: within 3 months of the last stellate ganglion block

The incidence of chronic neuropathic pain in the face or the neck after herpes zoster

次要结局

  • The duration of herpes zoster(Through study completion, an average of 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sameh Abdelkhalik Ahmed Ismaiel

Dr

Tanta University

研究点 (5)

Loading locations...

相似试验